PubRank

Su-Ying Liang

Author PubWeight™ 26.73‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Clinical practice patterns and cost effectiveness of human epidermal growth receptor 2 testing strategies in breast cancer patients. Cancer 2009 2.63
2 Effect of managed care insurance on the use of preventive care for specific ethnic groups in the United States. Med Care 2002 2.34
3 Variation in access to health care for different racial/ethnic groups by the racial/ethnic composition of an individual's county of residence. Med Care 2004 2.25
4 Trends in colonoscopy for colorectal cancer screening. Med Care 2007 1.89
5 The association of race, socioeconomic status, and health insurance status with the prevalence of overweight among children and adolescents. Am J Public Health 2003 1.53
6 The impact of financial incentives on physician productivity in medical groups. Health Serv Res 2002 1.47
7 Prescription drug dispensing limits and patterns. Manag Care Interface 2005 1.38
8 Are gatekeeper requirements associated with cancer screening utilization? Health Serv Res 2004 1.35
9 The effect of area HMO market share on cancer screening. Health Serv Res 2004 1.29
10 Challenges to the translation of genomic information into clinical practice and health policy: Utilization, preferences and economic value. Curr Opin Mol Ther 2008 1.08
11 Acculturation and colorectal cancer screening among older Latino adults: differential associations by national origin. J Gen Intern Med 2009 1.06
12 Moving beyond the typologies of managed care: the example of health plan predictors of screening mammography. Health Serv Res 2004 1.03
13 Assessing the effects of race and ethnicity on use of complementary and alternative therapies in the USA. Ethn Health 2005 0.99
14 Association of regional variation in primary care physicians' colorectal cancer screening recommendations with individual use of colorectal cancer screening. Prev Chronic Dis 2007 0.92
15 Variation in screening mammography and Papanicolaou smear by primary care physician specialty and gatekeeper plan (United States). Cancer Causes Control 2004 0.88
16 Medicare formulary coverage for top-selling biologics. Nat Biotechnol 2009 0.87
17 Capacity building for assessing new technologies: approaches to examining personalized medicine in practice. Per Med 2010 0.85
18 Out-of-pocket expenditures for oral contraceptives and number of packs per purchase. J Am Med Womens Assoc 2004 0.82
19 Genomic testing and therapies for breast cancer in clinical practice. J Oncol Pract 2011 0.81
20 Genomic testing and therapies for breast cancer in clinical practice. Am J Manag Care 2011 0.81
21 Gene expression profile testing for breast cancer and the use of chemotherapy, serious adverse effects, and costs of care. Breast Cancer Res Treat 2011 0.80
22 Willingness to recommend a health plan: who is dissatisfied and what don't they like? Am J Manag Care 2004 0.75